Splice-Site Variants in the Gene Encoding GABA-A Receptor Delta Subunit Are Associated with Amphetamine Use in Patients under Methadone Maintenance Treatment
Journal
International Journal of Molecular Sciences
Journal Volume
24
Journal Issue
1
Date Issued
2022-12-31
Author(s)
Lin, Yen-Feng
Chou, Wen-Hai
Liu, Tung-Hsia
Fang, Chiu-Ping
Kuo, Hsiang-Wei
Tsai, Shih-Jen
Wang, Sheng-Chang
Chung, Ren-Hua
Tsou, Hsiao-Hui
Chen, Andrew C H
Liu, Yu-Li
Abstract
Chronic opioid use disorder patients often also use other substances such as amphetamines. The gene-based analysis method was applied in the genomic database obtained from our previous study with 343 methadone maintenance treatment (MMT) patients. We found that the gene encoding gamma-aminobutyric acid type A receptors (GABA-A receptor) delta subunit isoforms (GABRD) was associated with amphetamine use in heroin dependent patients under MMT in Taiwan. A total of 15% of the 343 MMT patients tested positive for amphetamine in the urine toxicology test. Two genetic variants in the GABRD, rs2889475 and rs2376805, were found to be associated with the positive urine amphetamine test. They are located in the exon 1 of the splice variant and altered amino acid compositions (T126I, C/T, for rs2889475, and R252Q, G/A, for rs2376805). The CC genotype carriers of rs2889475 showed a four times higher risk of amphetamine use than those with TT genotype. The GG genotype carriers of rs2376805 showed a three times higher risk of amphetamine use than the AA genotype carriers. To our knowledge, this is the first report that demonstrated an association of the delta splice variant isoform in the GABA-A receptor with an increased risk of amphetamine use in MMT patients. Our results suggest that rs2889475 and rs2376805 may be indicators for the functional role and risk of amphetamine use in MMT patients.
Subjects
GABRD; amphetamine use; methadone maintenance treatment; polysubstance abuse; psychostimulant
SDGs
Publisher
MDPI
Type
journal article